Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

US Patent 7485633 · Granted Feb 3, 2009

Estimated economic value: $340,061,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human CD47-targeting single-domain antibody and use thereof2025
Use of exosome derived from decidual natural killer (dNK) cells or dNK cell subs2025
Substituted bicyclic compounds useful as T cell activators2024
Substituted bicyclic compounds useful as T cell activators2024
Immunomodulators2024
Naphthyridinone compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted naphthyridinone compounds useful as T cell activators2023
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022